<h1>Venus Remedies Secures EU-GMP Recertification for Cephalosporin, Carbapenem, and Oncology Production, Boosting European Market Growth Prospects.</h1> Pharma company Venus Remedies has renewed its European Good Manufacturing Practices (EU-GMP) certification from Infarmed, Portugal's National Authority of Medicines and Health Products. This renewal applies to its facility producing Cephalosporin, Carbapenem, and Oncology formulations. The certification underscores the company's commitment to quality control and positions it for growth in the European antibiotics and oncology markets, projected to reach USD 10.9 billion and USD 36.95 billion, respectively. This certification supports Venus Remedies' strategy to expand its market presence in Europe and globally, ensuring the supply of high-quality healthcare solutions.